
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Lung Cancer Update
00:00
Navigating CNS Effects in Cancer Treatment
This chapter emphasizes the need for clear communication between healthcare providers and patients regarding potential CNS effects from cancer treatments. It explores personal anecdotes and scientific insights into cognitive and neurological side effects, particularly highlighting the impact of ALK inhibitors.
Transcript
Play full episode